KRT10
Keratin, type I cytoskeletal 10
Also known as: CK10, K10, K1C10_HUMAN, KPP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13645
- Gene
- KRT10
- Ensembl
- ENSG00000186395
- Chromosome
- 17
- Canonical length
- 584 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene encodes a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
584 residues, UniProt reviewed canonical sequence.
>P13645|KRT10
1 MSVRYSSSKH YSSSRSGGGG GGGGCGGGGG VSSLRISSSK GSLGGGFSSG GFSGGSFSRG
61 SSGGGCFGGS SGGYGGLGGF GGGSFRGSYG SSSFGGSYGG IFGGGSFGGG SFGGGSFGGG
121 GFGGGGFGGG FGGGFGGDGG LLSGNEKVTM QNLNDRLASY LDKVRALEES NYELEGKIKE
181 WYEKHGNSHQ GEPRDYSKYY KTIDDLKNQI LNLTTDNANI LLQIDNARLA ADDFRLKYEN
241 EVALRQSVEA DINGLRRVLD ELTLTKADLE MQIESLTEEL AYLKKNHEEE MKDLRNVSTG
301 DVNVEMNAAP GVDLTQLLNN MRSQYEQLAE QNRKDAEAWF NEKSKELTTE IDNNIEQISS
361 YKSEITELRR NVQALEIELQ SQLALKQSLE ASLAETEGRY CVQLSQIQAQ ISALEEQLQQ
421 IRAETECQNT EYQQLLDIKI RLENEIQTYR SLLEGEGSSG GGGRGGGSFG GGYGGGSSGG
481 GSSGGGHGGG HGGSSGGGYG GGSSGGGSSG GGYGGGSSSG GHGGSSSGGY GGGSSGGGGG
541 GYGGGSSGGG SSSGGGYGGG SSSGGHKSSS SGSVGESSSK GPRYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KRT10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 14,581 nTPM
Expression across tissuesHPA
Tissue
- skin: 14,581 nTPM
- vagina: 881 nTPM
- cervix: 535 nTPM
- breast: 406 nTPM
- skeletal muscle: 115 nTPM
- salivary gland: 113 nTPM
Single-cell type
- suprabasal keratinocytes: 7,879 nCPM
- basal keratinocytes: 961 nCPM
- esophageal apical cells: 716 nCPM
- late primary spermatocytes: 623 nCPM
- esophageal suprabasal cells: 565 nCPM
- esophageal basal cells: 417 nCPM
Immune cell
- basophil: 13 nTPM
- memory B-cell: 11 nTPM
- eosinophil: 11 nTPM
- plasmacytoid DC: 8.1 nTPM
- NK-cell: 6.9 nTPM
- memory CD8 T-cell: 6.7 nTPM
Brain region
- choroid plexus: 5.9 nTPM
- white matter: 5.7 nTPM
- cerebellum: 4.8 nTPM
- hippocampal formation: 4.7 nTPM
- hypothalamus: 4.7 nTPM
- pons: 4.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KRT10.
Disease | AllUniProt
Conditions KRT10 is implicated in, by any mechanism.
- Epidermolytic hyperkeratosis 2A (EHK2A) MIM:620150
- Epidermolytic hyperkeratosis 2B, autosomal recessive (EHK2B) MIM:620707
- Ichthyosis, annular epidermolytic, 1 (AEI1) MIM:607602
- Ichthyosis with confetti (IWC) MIM:609165
- Ichthyosis histrix, Lambert type (IHL) MIM:146600
Disease | GeneticClinVar
41 pathogenic / likely-pathogenic of 287 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Epidermolytic hyperkeratosis 2A, autosomal dominant
- Congenital reticular ichthyosiform erythroderma
- Epidermolytic hyperkeratosis 2B, autosomal recessive
- Epidermolytic hyperkeratosis 1
- KRT10-related disorder
Disease | ImmuneIEDB
Conditions an epitope on KRT10 was assayed in.
- psoriasis T cell
ReferencesPubMed · IEDB
Publications for KRT10 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- An Autoimmune Basis for Raynaud's Phenomenon: Murine Model and Human Disease.
2018 · Arthritis Rheumatol · RCR 0.4 · 9 citations
Reference: T cellIEDB
3 publications
- Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells.
2004 · Clin Exp Immunol · RCR 2.6 · 126 citations - HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.
2005 · J Dermatol Sci · RCR 0.9 · 36 citations - Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis.
2006 · J Am Acad Dermatol · RCR 0.8 · 33 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cornification
- intermediate filament organization
- keratinocyte differentiation
- morphogenesis of an epithelium
- positive regulation of epidermis development
- protein heterotetramerization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KRT10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KRT10 as an antibody target. Whether an autoantibody or antibody against KRT10 could matter depends on whether native KRT10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KRT10 is annotated at the cell surface, where native KRT10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KRT10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...